Study reveals new strategy to improve and accelerate recovery from muscle injuries

Muscle injuries are common in the active population, and they cause the majority of player leaves in the world of sport.

Targeted drug therapy shows promise for ulcerative colitis remission

An international placebo-controlled study led by Cedars-Sinai suggests that a targeted drug therapy that was developed by researchers at Cedars-Sinai is safe and effective at

September 26, 2024

FDA Approves JAK Inhibitor That Addresses Anemia in Myelofibrosis

The FDA approved momelotinib (Ojjaara) as the first therapy specifically for intermediate- and high-risk myelofibrosis with anemia, GSK announced. Almost all patients with myelofibrosis develop

September 19, 2023

Syncona takes write-down on SwanBio as biotech halves workforce to focus on one gene therapy

UK life sciences investor Syncona has taken a write-down on its investment in private gene therapy biotech SwanBio, part of a broader hit to its

June 15, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.